400-808-1701 登录/注册购物车(0)

首页 > SCI期刊 > 医学期刊 > Progress In Neuro-psychopharmacology & Biological Psychiatry(非官网)

收藏该杂志

同大类学科其它级别期刊：

中科院 1区期刊 JCR Q1 期刊中科院 2区期刊 JCR Q2 期刊中科院 3区期刊 JCR Q3 期刊中科院 4区期刊 JCR Q4 期刊

Progress In Neuro-psychopharmacology & Biological Psychiatry

SCI SCIE

国际简称：PROG NEURO-PSYCHOPH 参考译名：神经精神药理学与生物精神病学进展

主要研究方向：医学-精神病学非预警期刊审稿周期：约1月

《神经精神药理学与生物精神病学进展》(Progress In Neuro-psychopharmacology & Biological Psychiatry)是一本由Elsevier Inc.出版的以医学-精神病学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
313 年发文量
4.2 IF影响因子
未开放 是否OA
114 H-index
1982 创刊年份
Bimonthly 出版周期
English 出版语言

Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject.

Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.

[ 查看全部 ]

投稿咨询加急咨询

Progress In Neuro-psychopharmacology & Biological Psychiatry期刊信息

ISSN：0278-5846
出版语言：English
是否OA：未开放
E-ISSN：1878-4216
出版地区：ENGLAND
是否预警：否
出版商：Elsevier Inc.
出版周期：Bimonthly
创刊时间：1982
开源占比：0.1014
Gold OA文章占比：26.79%
OA被引用占比：0.0329...
出版国人文章占比：0.12
出版撤稿占比：0
研究类文章占比：93.93%

Progress In Neuro-psychopharmacology & Biological Psychiatry CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

6.5

1.502

1.197

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q2	88 / 328	73%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Biological Psychiatry	Q2	17 / 54	69%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Progress In Neuro-psychopharmacology & Biological Psychiatry中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	CLINICAL NEUROLOGY 临床神经病学 NEUROSCIENCES 神经科学 PHARMACOLOGY & PHARMACY 药学 PSYCHIATRY 精神病学	2区 2区 2区 3区

Progress In Neuro-psychopharmacology & Biological Psychiatry JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CLINICAL NEUROLOGY	SCIE	Q1	61 / 296	79.6
学科：NEUROSCIENCES	SCIE	Q2	103 / 330	68.9
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	102 / 356	71.5
学科：PSYCHIATRY	SCIE	Q1	62 / 293	79
学科：CLINICAL NEUROLOGY	SCIE	Q1	55 / 296	81.59
学科：NEUROSCIENCES	SCIE	Q1	67 / 330	79.85
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	67 / 356	81.32
学科：PSYCHIATRY	SCIE	Q1	57 / 293	80.72

Progress In Neuro-psychopharmacology & Biological Psychiatry历年数据统计

影响因子

中科院分区

Progress In Neuro-psychopharmacology & Biological Psychiatry中国学者发文选摘

1、Aberrant structural-functional connectivity coupling in migraineurs is associated with mental behavioral scores and neurotransmitte
Author: Li, Yan; Huang, Mei; Shu, Kun; Chen, Keyang; Fu, Fangwang; Cao, Yungang; Liu, Kun; Wang, Hebo; Liu, Xiaozheng

Journal: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2026; Vol. 146, Issue , pp. -. DOI: 10.1016/j.pnpbp.2026.111673
2、Multidimensional reorganization of static and dynamic brain network architecture following rTMS in young children with autism spectrum disorder and co-occurring intellectual disabilit
Author: Kang, Jiannan; Wu, Juanmei; Li, Yuqi; Liu, Nan; Li, Xiaoli; Chen, He

Journal: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2026; Vol. 146, Issue , pp. -. DOI: 10.1016/j.pnpbp.2026.111674
3、Effects of CBT-I in modulating neuroplasticity in brain regions associated with insomnia disorder and serum 27-OHC level
Author: Shi, Xian; Fan, Xiaoxuan; Cai, Yixian; Luo, Zhenye; Liu, Yaxi; Feng, Simeng; Gan, Lutong; Wang, Qi; Chen, Liting; Pan, Jiyang

Journal: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2026; Vol. 146, Issue , pp. -. DOI: 10.1016/j.pnpbp.2026.111678
4、Serum IGF-1 and anxiety trajectories in Parkinson's diseas
Author: Chen, Shuai; Niu, Yu-Xin; Li, Chen-Hong; Xiang, Xue-Feng; Shao, Jing-Yu; Yang, Hong-Qi; Ma, Kai; Zhang, Jie-Wen

Journal: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2026; Vol. 146, Issue , pp. -. DOI: 10.1016/j.pnpbp.2026.111683
5、Regulation of short-term declarative memory by selective activation of the locus coeruleus-retrosplenial cortex dopaminergic pathway and its pathological alterations in Parkinson's diseas
Author: Yan, Yalong; Gao, Linyun; Qiang, Xiyu; Qiu, Yuxiang; Shen, Yixin; Mu, Chunyan; Tang, Chuanxi

Journal: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2026; Vol. 146, Issue , pp. -. DOI: 10.1016/j.pnpbp.2026.111680
6、Impairment of prefrontal cortex cognitive control functions in methamphetamine use disorder: A functional near-infrared spectroscopy stud
Author: Tian, Yang; Jiang, Linjun; Gang, Xianchen; Jia, Lianglun; Fu, Fabin; Tang, Shanshan; Wang, Xiaotao; Zhang, Xiangyang; Wang, Dongmei

Journal: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2026; Vol. 146, Issue , pp. -. DOI: 10.1016/j.pnpbp.2026.111690
7、Disordered connectivity configuration of triple-network model and visual-network in tobacco use disorde
Author: Liu, Yang; Zhang, Mengzhe; Tian, Ya; Zhou, Sha; Shen, Yufei; Ma, Longyao; Mei, Bohui; Wang, Weijian; Han, Shaoqiang; Zhang, Yong

Journal: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2026; Vol. 146, Issue , pp. -. DOI: 10.1016/j.pnpbp.2026.111703
8、The supportive association of inhibitory control with working memory updating among individuals with mild cognitive impairment: An empirical study based on event-related potentials and transcranial direct current stimulatio
Author: Fei, Yang; Liu, Ying; Wang, Jing; Yu, Xiaohong; Li, Cheng; Luo, Yuanrong; Du, Chao; Yin, Yueheng; Niu, Shuzhen; Guo, Min; Xing, Ying; Zhang, Yu; Li, Xianwen

Journal: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2026; Vol. 146, Issue , pp. -. DOI: 10.1016/j.pnpbp.2026.111693